Published by
@ShahidNShah
@ShahidNShah
During this 3 day CME course, experts in the field of genetic cardiology and cardiovascular genetics detail the important role of genetics, genomics, and pharmacogenetics in the diagnosis, risk stratification, and treatment of monogenetic, oligogenetic, and polygenic diseases affecting the heart and the blood vessels.
Topics covered will include genetics and genomics 101, pharmacogenetics, polygenic risk scores, variant interpretation, the molecular autopsy, and the diagnostic, prognostic, and therapeutic implications of genetic testing for patients with congenital heart disease, long QT syndrome, Brugada syndrome, hypertrophic/dilated/arrhythmogenic cardiomyopathy, coronary heart disease, hyperlipidemias, heart failure, pulmonary hypertension, cardiac amyloid, and the aortopathies.
Continue reading at cveducation.mayo.edu
October 7 to October 8, 2023
InterContinental San Francisco 888 Howard Street San Francisco, California 94103 United States
Connecting innovation decision makers to authoritative information, institutions, people and insights.
Medigy accurately delivers healthcare and technology information, news and insight from around the world.
Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.
© 2023 Netspective Media LLC. All Rights Reserved.
Built on Jun 5, 2023 at 1:40pm